Janux Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACRV
|
Acrivon Therapeutics, Inc. Common Stock | $6.47 | $223.86 M | -2.51 | 58 | $0 |
 ADAG
|
Adagene Inc. | $2.27 | $131.46 M | -6.77 | 174 | $18.11 M |
 ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.48 | $56.28 M | -5.86 | 2 | $0 |
 ANTX
|
AN2 Therapeutics, Inc. | $1.36 | $60.55 M | -0.81 | 41 | $0 |
 AVTE
|
Aerovate Therapeutics, Inc. | $2.60 | $597.48 M | -6.84 | 51 | $0 |
 CSBR
|
Champions Oncology, Inc. | $4.30 | $62.53 M | -6.39 | 210 | $50.16 M |
 CYT
|
Cyteir Therapeutics, Inc. | $3.02 | $108.71 M | -3.25 | 46 | $0 |
 ELYM
|
Eliem Therapeutics, Inc. | $5.11 | $258.33 M | -17.08 | 9 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $32.36 | $1.65 B | -11.47 | 108 | $0 |
 FENC
|
Fennec Pharmaceuticals Inc. | $5.20 | $187.43 M | 171.5 | 29 | $21.25 M |
 HRMY
|
Harmony Biosciences Holdings, Inc. | $33.51 | $1.73 B | 13.15 | 246 | $582.02 M |
 KROS
|
Keros Therapeutics, Inc. | $55.39 | $1.76 B | -9.45 | 160 | $151,000 |
 MLYS
|
Mineralys Therapeutics, Inc. | $12.03 | $652.38 M | -6.03 | 28 | $0 |
 MNOV
|
MediciNova, Inc. | $2.05 | $67.19 M | -8.06 | 13 | $1.00 M |
 MOLN
|
Molecular Partners AG | $5.42 | $135.05 M | -2.03 | 167 | $7.04 M |
 RZLT
|
Rezolute, Inc. | $4.90 | $229.57 M | -5.02 | 59 | $0 |